Personal CFO Solutions’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$367K Buy
3,821
+53
+1% +$5.43K 0.05% 335
2026
Q1
$411K Sell
3,768
-101
-3% -$9.63K 0.06% 290
2025
Q4
$314K Sell
3,869
-192
-5% -$16.5K 0.05% 351
2025
Q3
$355K Hold
4,061
0.06% 290
2025
Q2
$337K Buy
4,061
+12
+0.3% +$1K 0.06% 296
2025
Q1
$340K Sell
4,049
-390
-9% -$36.3K 0.07% 279
2024
Q4
$409K Sell
4,439
-92
-2% -$8.85K 0.08% 239
2024
Q3
$421K Sell
4,531
-138
-3% -$12K 0.06% 308
2024
Q2
$384K Sell
4,669
-835
-15% -$61.3K 0.06% 314
2024
Q1
$365K Sell
5,504
-70
-1% -$4.32K 0.06% 346
2023
Q4
$316K Buy
5,574
+336
+6% +$17.6K 0.05% 365
2023
Q3
$285K Buy
5,238
+59
+1% +$3.5K 0.06% 336
2023
Q2
$348K Sell
5,179
-1,028
-17% -$62.7K 0.07% 299
2023
Q1
$319K Sell
6,207
-392
-6% -$19K 0.07% 292
2022
Q4
$304K Buy
6,599
+321
+5% +$15K 0.06% 293
2022
Q3
$318K Sell
6,278
-85
-1% -$4.25K 0.08% 241
2022
Q2
$290K Sell
6,363
-122
-2% -$5.46K 0.07% 274
2022
Q1
$301K Buy
6,485
+275
+4% +$12.3K 0.06% 326
2021
Q4
$312K Buy
6,210
+30
+0.5% +$1.55K 0.06% 310
2021
Q3
$328K Buy
6,180
+396
+7% +$22.3K 0.07% 265
2021
Q2
$353K Sell
5,784
-73
-1% -$3.88K 0.07% 247
2021
Q1
$286K Sell
5,857
-260
-4% -$12.2K 0.06% 274
2020
Q4
$248K Buy
+6,117
New +$219K 0.06% 292

Other funds holding LMAT

Personal CFO Solutions's LMAT Position: Q2 2026 in Review

Personal CFO Solutions increased its LeMaitre Vascular (LMAT) stake by 1.4% in Q2 2026, buying an estimated $5.43K and bringing the position to 3,821 shares worth $367K. The position accounts for 0.05% of the portfolio, ranked #335.

Personal CFO Solutions first reported a position in LMAT in Q4 2020 and has held it in 23 quarters since. The position peaked at $421K in Q3 2024. 326 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.

  • Personal CFO Solutions held 3,821 shares of LeMaitre Vascular worth $367K as of Q2 2026.
  • Personal CFO Solutions bought 53 LeMaitre Vascular shares in Q2 2026, an estimated $5.43K.
  • LeMaitre Vascular made up 0.05% of Personal CFO Solutions's portfolio in Q2 2026, its #335 holding.
  • Personal CFO Solutions first reported a position in LeMaitre Vascular in Q4 2020 and has held it in 23 quarters since.
  • Personal CFO Solutions's LeMaitre Vascular position peaked at $421K in Q3 2024.
  • 326 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.

Based on Personal CFO Solutions's 13F filing for Q2 2026, filed 7 Aug 2026.